Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on June 2, 2025
Vantive to Invest More Than $1 Billion in Advancing Kidney Care and Vital Organ Support Through Digitally-Enabled Therapies
GlobeNewswire
·
June 2, 2025
Five-year global investment to fuel R…
Wildfire Smoke is Already Suffocating Canada – Here’s How to Save Your Lungs
GlobeNewswire
·
June 2, 2025
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- With wildfire season already impacting air quality across parts of Canada, Lung Health Foundation (LHF) is urging Canadians to take steps now to protect their breathing as part of Clean Air Day on Wednesday, June …
The Journal of Clinical Oncology Publishes Five-year Analysis of Amtagvi® (lifileucel) in Patients with Advanced Melanoma
GlobeNewswire
·
June 2, 2025
One-time Amtagvi Treatment Continues to Show Deep, Durable Responses and Meaningful Survival One Third of Responses Remain Ongoing without Subsequent Treatment after Five Years Simultaneous Presentation at ASCO 2025 SAN CARLOS, Calif., June 02, 2025 ( …
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
GlobeNewswire
·
June 2, 2025
REYKJAVIK, Iceland, June 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies …
Cytrellis Strengthens Leadership Team in Support of Accelerated Commercial Growth of ellacor® Platform
GlobeNewswire
·
June 2, 2025
WOBURN, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Cytrellis Biosystems Inc., a medical technology company specializing in novel aesthetic solutions, today announced the appointment of Karyn Siemasko, Ph.D., as Vice President of Clinical and Medical Affairs; …
Evosep unveils new instrumentation and partnership at ASMS 2025
GlobeNewswire
·
June 2, 2025
BALTIMORE, Md., June 02, 2025 (GLOBE NEWSWIRE) -- Evosep®, a global leader in proteomics solutions, is proud to announce the launch of the Evosep Eno™, a robust, high-throughput separation tool preparing for next generation workflow integration for LC-MS …
Solera Health Unveils Enhanced AI Governance Framework for Responsible and Transparent Use of Artificial Intelligence in Digital Health
GlobeNewswire
·
June 2, 2025
PHOENIX, June 02, 2025 (GLOBE NEWSWIRE) -- Solera Health, the premier digital health delivery company creating flexible solutions to seamlessly connect people to on-benefit care via health plans and employers, today announced the launch of its Enhanced AI …
Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma
GlobeNewswire
·
June 2, 2025
TRIgnite-1 study shows an overall response rate (ORR) of 74% across nine dose levels, in heavily pretreated patients with a median of six prior lines of therapy ORR is remarkably high in patients with no prior CAR-T or bispecific therapies (84%) as well as …
Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types
GlobeNewswire
·
June 2, 2025
SALT LAKE CITY, June 02, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced new molecular residual disease (MRD) clinical data from the MONSTAR-SCREEN 3 study, a …
PathAI and Northwestern Medicine Announce Strategic Collaboration to Deploy the AISight® Digital Pathology Platform and Co-Develop New AI Diagnostics
GlobeNewswire
·
June 2, 2025
BOSTON and CHICAGO, June 02, 2025 (GLOBE NEWSWIRE) -- PathAI, a leading provider of AI-powered pathology solutions, and Northwestern Medicine, Chicago’s premier integrated academic health system, today announced a strategic collaboration to transform …
Actuate Therapeutics Shares Highlights from KOL Event on Positive Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer
GlobeNewswire
·
June 2, 2025
- Expert Insights on Clinical Relevance and Scientific Rationale - The replay of the event is available on the Investor Relations section of the Actuate website CHICAGO and FORT WORTH, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. ( …
New Independent Review Paper Strengthens Therapeutic Rationale for Artelo’s FABP Inhibitor Program in Anxiety and Depression
GlobeNewswire
·
June 2, 2025
SOLANA BEACH, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, …
TerrAscend Announces Chief Financial Officer Transition Plan
GlobeNewswire
·
June 2, 2025
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX: TSNDF), a leading North American cannabis company, today announced that Keith Stauffer, Chief Financial Officer, will be departing the Company on …
Xilio Therapeutics Announces Pricing of $50.0 Million Public Offering
GlobeNewswire
·
June 2, 2025
WALTHAM, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced the pricing …
Pinnacle Treatment Centers Introduces New Opioid Treatment Options in California: Sublocade and Vivitrol
GlobeNewswire
·
June 2, 2025
Canoga Park, California, June 02, 2025 (GLOBE NEWSWIRE) -- Aegis Treatment Centers, part of the Pinnacle Treatment Centers Family of Companies, a leader in providing evidence-based care for individuals struggling with Substance Use Disorder (SUD), is …
Rakovina Therapeutics Announces 2025 Q1 Financial Results and Provides Corporate Update
GlobeNewswire
·
June 2, 2025
VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing novel DNA-damage response (DDR) cancer therapies powered by artificial …
SS Innovations to Ring the Nasdaq Opening Bell on Tuesday, June 3, 2025
GlobeNewswire
·
June 2, 2025
FORT LAUDERDALE, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and …
LogicMark, Inc. Common Stock to Commence Trading on OTC Markets as the Company Continues Advancing Growth Initiatives
GlobeNewswire
·
June 2, 2025
LOUISVILLE, Ky., June 02, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (the “Company”), a provider of personal emergency response systems (“PERS”), health communication devices, and technology for the growing care economy, today announced that it expects that …
Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
31% confirmed ORR (8 responses in 26 evaluable patients) across B7-H4 high tumors at intermediate doses 44% confirmed ORR (7 responses in 16 evaluable patients) in the subset of patients with ≤4 prior lines of therapy CAMBRIDGE, Mass., June 02, 2025 (GLOBE …
IMUNON CEO RECAPS A YEAR OF CLINICAL ACHIEVEMENT AND SOLID FUNDAMENTALS
GlobeNewswire
·
June 2, 2025
Outstanding Phase 2 Results will be discussed at the 2025 ASCO in an Oral Presentation and featured in peer reviewed medical journal Gynecologic Oncology Phase 3 OVATION 3 Study in progress LAWRENCEVILLE, N.J. , June 02, 2025 (GLOBE NEWSWIRE) -- IMUNON, …